Skip to content
A8782Assembly2009-2010 SessionSame asS6937

Directs the department of health to evaluate and report on Medicaid prescription drug reimbursement to retail pharmacies

Sponsor RoAnn DestitoAD-116+15 co-sponsorsAffects Health
Status
In Senate Committee
Health
Impact
Pending
Passage
Pending

Bill progress

Step 5 of 7

In Senate · Health

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

History

  1. Referred to health
  2. Delivered to senate
  3. Passed assembly
  4. Amended on third reading 8782a
  5. Ordered to third reading cal.623
  6. Returned to assembly
  7. Died in senate
  8. Referred to rules
  9. Delivered to senate
  10. Passed assembly
  11. Ordered to third reading rules cal.413
  12. Rules report cal.413
Show 4 earlier actions
  1. Reported
  2. Reported referred to rules
  3. Reported referred to ways and means
  4. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S6937Senate

Directs the department of health to evaluate and report on Medicaid prescription drug reimbursement to retail pharmacies

In Senate Committee · Health · Sponsor David J. Valesky

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

BILL NUMBER:A8782A

Title of bill

An act to direct the department of health to evaluate and report on Medicaid prescription drug reimbursement to retail pharma- cies

Purpose or general idea of bill

This bill directs the Department of Health to evaluate and report on Medicaid prescription drug reimburse- ment to retail pharmacies.

Summary of specific provisions

Section one of the bill creates a work- group within the Department of Health to assist the Commissioner of Health in studying Medicaid prescription drug reimbursement to retail pharmacies. Section two outlines the different factors to be considered in the study. Section three requires the Commissioner of Health to issue a report to the Governor and the Legislature. Section four sets forth the effective date.

Justification

It has become important for the legislature to have access to factual information on which to base policy and budget deci- sions with regard to payments to pharmacies. This legislation requires the Health Department, working with representatives of organized pharma- cy and other stakeholders, to gather information and prepare a report to inform about the adequacy of present reimbursement in terms of actual costs both for medications and professional services.

Compounding the pharmacy reimbursement matter further is the use of the term 'Average Wholesale Price' (AWP) that, combined with a discount, forms the payment formula for brand drugs. For generics, New York State law allows the Department of Health to calculate 'State Maximum Allow- able Cost' (SMAC). Pharmacies report that SMAC pricing is not based on any known methodology and it brings payment levels unrealistically low. Access to generics is an important key to our cost-containment strate- gies, and we should have confidence that our reimbursement policy is set appropriately.

As enumerated in this legislation, pharmacy overhead costs cover a wide range of elements that must be considered as part of a fair and reason- able payment standard. For consumers, the professional service compo- nents may represent the real value of having a local pharmacy with an accessible pharmacist, who has filled the prescription, checked for drug interactions and can provide important information about how to take the medicine prescribed for them. In this time of limited resources, it becomes more important that our Medicaid and EPIC beneficiaries derive the maximum therapeutic benefit from the medicines they are prescribed so that they can remain at home living independently as long as possi- ble. Local pharmacies represent healthcare outreach into communities and a valuable cost-containment strategy.

Prior legislative history

2009: A.8782 - Passed Assembly.

Fiscal implications

To be determined.

Effective date

Immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.